Department of Urology, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine, Bucheon, Korea.
Investig Clin Urol. 2019 Nov;60(6):488-495. doi: 10.4111/icu.2019.60.6.488. Epub 2019 Sep 23.
To evaluate the success rate and patient satisfaction with the readjustable midurethral sling (REMEEX system) for the treatment of stress urinary incontinence (SUI) with intrinsic sphincter deficiency (ISD) or recurrent SUI in obese and non-obese women.
Between August 2009 and August 2015, 70 patients who treated with the REMEEX system were stratified into normal, overweight and obesity groups according to body mass index. Objective surgical outcomes were evaluated using a 1-hour pad test that was performed 3 months after surgery. The subjective outcomes and degree of patient satisfaction were evaluated 3 months and 1 year after surgery.
Twenty-six normal weight, 31 overweight, and 13 obese women were included in the study. The objective cure rate determined using the 1-hour pad test revealed that 11 women (42.3%) were cured and 15 (57.7%) had improved in the normal weight group, respectively, compared with 16 (51.6%) and 15 (48.4%) in the overweight group and 6 (46.2%) and 7 (53.8%) in the obese group, respectively (p=0.78). One year after surgery, the subjective success rate was 91.5% in the normal weight group, 93.5% in the overweight group and 92.3% in the obese group. A total of 84.7%, 77.4%, and 77.0% of normal weight, overweight and obese women were very satisfied or satisfied 1 year after surgery, respectively. All groups showed similar success rates and satisfaction.
The REMEEX procedure is equally effective in obese and normal weight women with ISD-type SUI or recurrent SUI.
评估可调节中段尿道吊带（REMEEX 系统）治疗伴有内括约肌缺陷（ISD）或肥胖和非肥胖女性复发性压力性尿失禁（SUI）的成功率和患者满意度。
2009 年 8 月至 2015 年 8 月，根据体重指数（BMI）将 70 例接受 REMEEX 系统治疗的患者分为正常、超重和肥胖组。术后 3 个月，采用 1 小时垫试验评估客观手术结果。术后 3 个月和 1 年评估主观结果和患者满意度。
研究纳入 26 例正常体重、31 例超重和 13 例肥胖女性。术后 1 小时垫试验结果显示，11 例（42.3%）正常体重组患者治愈，15 例（57.7%）患者改善，而超重组分别为 16 例（51.6%）和 15 例（48.4%），肥胖组分别为 6 例（46.2%）和 7 例（53.8%）（p=0.78）。术后 1 年，正常体重组主观成功率为 91.5%，超重组为 93.5%，肥胖组为 92.3%。术后 1 年，正常体重、超重和肥胖组非常满意或满意的患者比例分别为 84.7%、77.4%和 77.0%。所有组的成功率和满意度相似。
REMEEX 手术对伴有 ISD 型 SUI 或复发性 SUI 的肥胖和正常体重女性同样有效。
